Concepedia

Albert Torri

AT

Statistics

Publications

23

Citations

649

H-Index

15

Active since

2000

Affiliations

Regeneron (United States)(Current)

Bristol-Myers Squibb (United States)

Janssen (United States)

Pfizer (United States)

United States Food and Drug Administration

Albert Torri is an author at Regeneron (United States) specializing in medicine, drug discovery, and immunology.

Top concepts

Publications per year

2000–2023

23

Publications

23

2015 White Paper on Recent Issues in Bioanalysis: Focus on New Technologies and Biomarkers (Part 3 – Lba, Biomarkers and Immunogenicity)

Lakshmi Amaravadi, An Song, Heather Myler et al. · Bioanalysis · 2015 · 74 citations · Full text

2016 White Paper on Recent Issues in Bioanalysis: Focus on Biomarker Assay Validation (BAV): (Part 3 – Lba, Biomarkers and Immunogenicity)

Susan Richards, Lakshmi Amaravadi, Renuka Pillutla et al. · Bioanalysis · 2016 · 58 citations · Full text

, , +33

Structure–activity relationships for a series of thiobenzamide influenza fusion inhibitors derived from 1,3,3-Trimethyl-5-hydroxy-cyclohexylmethylamine

Kuo-Long Yu, Albert Torri, Guangxiang Luo et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 51 citations

, , +6

2014 White Paper on Recent Issues in Bioanalysis: A Full Immersion in Bioanalysis (Part 2 – Hybrid LBA/LCMS, ELN & Regulatory Agencies’ Input)

Dawn Dufield, Hendrik Neubert, Fabio Garofolo et al. · Bioanalysis · 2014 · 50 citations

, , +25

The Long-Term Prognosis of Renal Transplant in Patients With Systemic Vasculitis

Gabriella Moroni, Albert Torri, Beniamina Gallelli et al. · American Journal of Transplantation · 2007 · 49 citations · Full text

1–5 of 23